51
Pharma & HealthcareHold
PGIM India Healthcare
PGIM India · Direct–Growth · rank #9 of 19 by Smart Score
Data updated
Trailing returns
1 Year
15.2%
+19.9% vs index
3 Years
—
5 Years
—
Since launch
9.2%
Year-by-year performance
2025
-1.0%-8.7% vs index
2026
+17.3%+23.3% vs index
Why this score
PGIM India Healthcare scores 51/100 — #9 of 19 Pharma & Healthcare fund (Hold). It stands out for volatility and alpha — beating 91% of peers on volatility. The main drag is its sharpe ratio (better than only 16% of peers).
Each bar shows the fund's percentile vs Pharma & Healthcare peers — a longer bar beats more of the category.
Sharpe ratio0.21 · 16th percentile in category
Volatility13.12 · 91st percentile in category
Fund size130.33 Cr · 8th percentile in category
Alpha7.41 · 84th percentile in category
Sortino ratio0.28 · 17th percentile in category
Expense ratio0.96% · 71st percentile in category
Top holdings
1.Divi's Laboratories Ltd10.36%
2.Sun Pharmaceutical Industries Ltd10.25%
3.Torrent Pharmaceuticals Ltd8.49%
4.Ajanta Pharma Ltd4.96%
5.Max Healthcare Institute Ltd4.71%
31 disclosed equity positions · portfolio as of Sept 2026 · weights are % of total corpus.